Case of Kawasaki disease in NICU

Pediatrics International

Volumn 45, Issue 5, 2003, Pages 580-583

  Iino, Mayu ^a   Shiraishi, Hirohiko ^a   Igarashi, Hiroshi ^a   Honma, Yoko ^a   Momoi, Mariko Y ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Intravenous gamma globulin; Kawasaki disease; NICU; Ulinastatin

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; IMMUNOGLOBULIN; ULINASTATIN;

APNEA; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CORONARY ARTERY; CORONARY ARTERY ANEURYSM; DISEASE COURSE; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG MEGADOSE; DYSPNEA; FEVER; FOLLOW UP; GASTROINTESTINAL REFLUX; GESTATIONAL AGE; HEART CATHETERIZATION; HUMAN; INFECTION; LABORATORY TEST; MALE; MEDICAL SCHOOL; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEWBORN; NEWBORN INTENSIVE CARE; PERICARDIAL EFFUSION; PNEUMONIA; PRIORITY JOURNAL; RASH; SEPSIS; TREATMENT OUTCOME;

CORONARY ANGIOGRAPHY; HUMANS; INFANT; INTENSIVE CARE UNITS, NEONATAL; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME;

EID: 0242660048     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200X.2003.01766.x     Document Type: Article

References (10)

1. Yashiro M, Nakamura Y, Yanagawa H. Changes in the age specific incidence rates of Kawasaki Disease in patients reported to the 15th nationwide survey. J. Jpn. Pediatr. Soc. 2001; 105: 437-41.
2. Yashiro M, Ooki I, Nakamura Y, Yanagawa H. Epidemiologic pictures of final cases of Patients with Kawasaki disease reported in 15 nationwide surveys. J. Jpn. Pediatr. Soc. 2000; 104: 1179-83.
3. Tsuchida S, Yamanaka T, Tsuchida R, Nakamura Y, Yashiro M, Yamagawa H. Epidemiology of infant Kawasaki disease with a report of the youngest neonatal case ever reported in Japan. Acta Pediatr. Scand. 1996; 85: 995-7.
4. Takahashi N, Nishida H, Kato H, Imanishi K, Sakata Y, Uchiyama T. Exanthematous disease induced by toxic shock syndrome toxin-1 in the early neonatal period. Lancet 1998; 351; 1614-9.
5. Leung DYM, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM. Toxic shock syndrome toxin - secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1993; 342; 1385-8.
6. Zhang T, Yanagawa H, Oki I et al. Factors related to cardiac sequelae of Kawasaki disease. Eur. J. Pediatr. 1999; 158; 694-7.
7. Han RK, Silverman ED, Newman A, McCrindle BW. Management and outcome of persistent or recurrent fever after initial intraveous gamma globulin therapy in acute Kawasaki disease. Arch. Pediatr. Adolesc. Med. 2000; 154: 694-9.
8. Nakano M, Yamada S, Hayashi Y, Morishita M, Iwaki T, Toyoda M. Preventive effect of selective combination therapy of ulinastatin and immunoglobulin for coronary artery aneurysm formation in Kawasaki disease. Prog. Med. 1997; 17: 134-40.
9. Suzuki N, Sekiguchi M, Kouno C, Inukai K, Kito H, Kobayashi H. Rupture of coronary aneurysm in Kawasaki disease. Pediatr. Int. 1999; 41: 318-20.
10. Zaitsu M, Hamasaki Y, Tashiro K et al. Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease. J. Infect. Dis. 2000; 181 (3): 1101-9.